Amazon announced Prime members can access new upfront pricing to treat five common conditions like erectile disfunction and ...
BofA lowered its rating of Hims & Hers (HIMS) to underperform from buy, citing Amazon’s (AMZN) push into the hair loss and ...
BofA downgraded Hims & Hers (HIMS) to Underperform from Buy with a price target of $18, down from $32. Amazon (AMZN) launched a cash-pay ...
The move into lifestyle treatments is seen as a challenge to companies like Hims & Hers, which saw its stock value drop ...
Shares of Hims & Hers ($HIMS) plummeted nearly 15% on Thursday after Amazon.com, Inc. ($AMZN) launched its new Amazon One ...